Switzerland· 68094004
Sunitinib Viatris 12.5 mg, Hartkapseln
A sunitinib product containing sunitinibum, registered in Switzerland by Viatris Pharma GmbH and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Sunitinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EX01 (sunitinib), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Sunitinib · ATC L01EX01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of sunitinib costs, country by country.
Normalised to the WHO defined daily dose (33 mg), so markets compare like for like.
- Switzerland: $100.88 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Sunitinib · price per daily dose (33 mg)
USD · FX 28 Sept 2026
- CH Switzerland$100.88
The record
At a glance
Swissmedic (Switzerland)- Active substance
- sunitinibum
- Manufacturer
- Viatris Pharma GmbH
- Country
- Switzerland (CH)
- ATC code
- L01EX01
- ATC class
- Sunitinib
- Defined daily dose
- 33 mg, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680680940044Blist 28 StkCHF 887.35
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
464 interactions on record for sunitinib.
Graded by severity as the source publishes them — 99 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sunitinib · interactions on record
464 records
- 99 severe
- 362 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sunitinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSUNITINIB ACCORDAccord Healthcare S.L.U., Barcelona
- NetherlandsEgotux 12,5 mg harde capsulesGenepharm S.A.
- PolandKlertisEgis Pharmaceuticals PLC
- SpainSUNITINIB ACCORD 12,5 mg CAPSULAS DURAS EFGAccord Healthcare S.L.U.
- SwedenSunitinib Accord 12,5 mg Kapsel, hårdAccord Healthcare S.L.U.
- United KingdomSunitinib 12.5mg capsulesDr Reddy's Laboratories (UK) Ltd
- FranceSUNITINIB ACCORD 12,5 mg, géluleACCORD HEALTHCARE (ESPAGNE)
- FinlandSunitinib AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Sunitinib Bluefish, Sunitinib G.L.
- Belgium · Sunitinib Sandoz, Sunitinib Teva
- Bulgaria · Суганет, Сунитиниб Алкалоид-Инт
- Cyprus · Sunitinib Msn, Sunitinib Sapiens
- Czechia · Sunitinib Pharmagen, Sunitinib Sandoz
- Germany · Sunitinib Al, Sunitinib Aqvida
- Denmark · Sunitinib Medical Valley, Sunitinib Sandoz
- Estonia · Sunitinib Sandoz, Sunitinib Teva
- Spain · Sunitinib Bluepharma Indústria, Sunitinib Dr. Reddys
- Finland · Sunitinib Ratiopharm, Sunitinib Sandoz
- France · Sunitinib Arrow, Sunitinib Biogaran
- United Kingdom (Northern Ireland) · Sunitinib Amarox, Sunitinib Dr. Reddy’s
- Greece · Egotux, Sunidem
- Croatia · Sunitinib Alkaloid-Int, Sunitinib Be Pharma
- Hungary · Klertis, Suganet
- Ireland · Sunitinib Bluefish, Sunitinib Rowex
- Iceland · Sunitinib Accord, Sunitinib Demo
- Italy · Sunitinib Aurobindo, Sunitinib Dr. Reddy’s
- Liechtenstein · Sunitinib Accord, Sutent
- Lithuania · Klertis, Sunitinib G.L. Pharma
- Luxembourg · Sunitinib Eg, Sunitinib Teva
- Latvia · Sunitinib Be Pharma, Sunitinib G.L. Pharma
- Malta · Sunitinib Dr. Reddy’s, Sunitinib Medichem
- Netherlands · Egotux, Klertis
- Norway · Sunitinib Accord, Sunitinib Medical Valley
- Poland · Klertis, Sunitinib Bluefish
- Portugal · Sunitinib Bluepharma, Sunitinib Bluepharma Indústria
- Romania · Klertis, Sunitinib Alkaloid-Int
- Sweden · Sunitinib Bluefish, Sunitinib Eugia
- Slovenia · Sunitinib Alkaloid-Int, Sunitinib Msn
- Slovakia · Klertis, Sunitinib G.L. Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce4b7385-3117-4c43-a252-2fbd95466cbc GET /v1/drugs/ce4b7385-3117-4c43-a252-2fbd95466cbc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "sunitinibum 12.5 mg",
"valid_from": "2023-12-01",
"limitations": "[{\"description\":\"Behandlung von Patienten mit malignem gastrointestinalem Stromatumor (GIST) bei Resistenz oder Intoleranz auf Imatinib Mesylat.<br>\\nBehandlung von Patienten mit fortgeschrittenem und/oder metastasierendem Nierenzellkarzinom.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2021-11-01\"}]",
"galenic_form": "Kaps 12.5 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2021-11-01",
"self_retention_pct": 10
}See everything about sunitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.